IMMUNOSTIMULATOR
To provide an immunostimulator having higher cell-mediated immunity inductive action (particularly, CD8T cell inductive action and/or CD4T cell inductive action).SOLUTION: An immunostimulator contains (A) cationic lipid-containing lipid particles a, and at least one selected from the group consistin...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MORI YASUKO HASEDA YASUNARI SUZUKI AKIRA AOEDA HIROTAKA MUNAKATA RISA |
| description | To provide an immunostimulator having higher cell-mediated immunity inductive action (particularly, CD8T cell inductive action and/or CD4T cell inductive action).SOLUTION: An immunostimulator contains (A) cationic lipid-containing lipid particles a, and at least one selected from the group consisting of CpG oligodeoxynucleotide and aluminum salt, or contains (B) cationic lipid-containing lipid particles b with a particle size of less than 100 nm.SELECTED DRAWING: None
【課題】細胞性免疫の誘導作用（特に、CD8T細胞誘導作用及び／又はCD4T細胞誘導作用）がより高い免疫賦活剤を提供すること。【解決手段】（A）カチオン性脂質含有脂質粒子a、並びにCpGオリゴデオキシヌクレオチド及びアルミニウム塩からなる群より選択される少なくとも1種を含有する、又は（B）粒径100nm未満のカチオン性脂質含有脂質粒子bを含有する、免疫賦活剤。【選択図】なし |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2020090445A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2020090445A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2020090445A3</originalsourceid><addsrcrecordid>eNrjZBDw9PUN9fMPDvH0DfVxDPEP4mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgZGBgaWBiYmpo7GRCkCAGFwHkg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMMUNOSTIMULATOR</title><source>esp@cenet</source><creator>MORI YASUKO ; HASEDA YASUNARI ; SUZUKI AKIRA ; AOEDA HIROTAKA ; MUNAKATA RISA</creator><creatorcontrib>MORI YASUKO ; HASEDA YASUNARI ; SUZUKI AKIRA ; AOEDA HIROTAKA ; MUNAKATA RISA</creatorcontrib><description>To provide an immunostimulator having higher cell-mediated immunity inductive action (particularly, CD8T cell inductive action and/or CD4T cell inductive action).SOLUTION: An immunostimulator contains (A) cationic lipid-containing lipid particles a, and at least one selected from the group consisting of CpG oligodeoxynucleotide and aluminum salt, or contains (B) cationic lipid-containing lipid particles b with a particle size of less than 100 nm.SELECTED DRAWING: None
【課題】細胞性免疫の誘導作用（特に、CD8T細胞誘導作用及び／又はCD4T細胞誘導作用）がより高い免疫賦活剤を提供すること。【解決手段】（A）カチオン性脂質含有脂質粒子a、並びにCpGオリゴデオキシヌクレオチド及びアルミニウム塩からなる群より選択される少なくとも1種を含有する、又は（B）粒径100nm未満のカチオン性脂質含有脂質粒子bを含有する、免疫賦活剤。【選択図】なし</description><language>eng ; jpn</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200611&DB=EPODOC&CC=JP&NR=2020090445A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200611&DB=EPODOC&CC=JP&NR=2020090445A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MORI YASUKO</creatorcontrib><creatorcontrib>HASEDA YASUNARI</creatorcontrib><creatorcontrib>SUZUKI AKIRA</creatorcontrib><creatorcontrib>AOEDA HIROTAKA</creatorcontrib><creatorcontrib>MUNAKATA RISA</creatorcontrib><title>IMMUNOSTIMULATOR</title><description>To provide an immunostimulator having higher cell-mediated immunity inductive action (particularly, CD8T cell inductive action and/or CD4T cell inductive action).SOLUTION: An immunostimulator contains (A) cationic lipid-containing lipid particles a, and at least one selected from the group consisting of CpG oligodeoxynucleotide and aluminum salt, or contains (B) cationic lipid-containing lipid particles b with a particle size of less than 100 nm.SELECTED DRAWING: None
【課題】細胞性免疫の誘導作用（特に、CD8T細胞誘導作用及び／又はCD4T細胞誘導作用）がより高い免疫賦活剤を提供すること。【解決手段】（A）カチオン性脂質含有脂質粒子a、並びにCpGオリゴデオキシヌクレオチド及びアルミニウム塩からなる群より選択される少なくとも1種を含有する、又は（B）粒径100nm未満のカチオン性脂質含有脂質粒子bを含有する、免疫賦活剤。【選択図】なし</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBDw9PUN9fMPDvH0DfVxDPEP4mFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8V4BRgZGBgaWBiYmpo7GRCkCAGFwHkg</recordid><startdate>20200611</startdate><enddate>20200611</enddate><creator>MORI YASUKO</creator><creator>HASEDA YASUNARI</creator><creator>SUZUKI AKIRA</creator><creator>AOEDA HIROTAKA</creator><creator>MUNAKATA RISA</creator><scope>EVB</scope></search><sort><creationdate>20200611</creationdate><title>IMMUNOSTIMULATOR</title><author>MORI YASUKO ; HASEDA YASUNARI ; SUZUKI AKIRA ; AOEDA HIROTAKA ; MUNAKATA RISA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2020090445A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MORI YASUKO</creatorcontrib><creatorcontrib>HASEDA YASUNARI</creatorcontrib><creatorcontrib>SUZUKI AKIRA</creatorcontrib><creatorcontrib>AOEDA HIROTAKA</creatorcontrib><creatorcontrib>MUNAKATA RISA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MORI YASUKO</au><au>HASEDA YASUNARI</au><au>SUZUKI AKIRA</au><au>AOEDA HIROTAKA</au><au>MUNAKATA RISA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMMUNOSTIMULATOR</title><date>2020-06-11</date><risdate>2020</risdate><abstract>To provide an immunostimulator having higher cell-mediated immunity inductive action (particularly, CD8T cell inductive action and/or CD4T cell inductive action).SOLUTION: An immunostimulator contains (A) cationic lipid-containing lipid particles a, and at least one selected from the group consisting of CpG oligodeoxynucleotide and aluminum salt, or contains (B) cationic lipid-containing lipid particles b with a particle size of less than 100 nm.SELECTED DRAWING: None
【課題】細胞性免疫の誘導作用（特に、CD8T細胞誘導作用及び／又はCD4T細胞誘導作用）がより高い免疫賦活剤を提供すること。【解決手段】（A）カチオン性脂質含有脂質粒子a、並びにCpGオリゴデオキシヌクレオチド及びアルミニウム塩からなる群より選択される少なくとも1種を含有する、又は（B）粒径100nm未満のカチオン性脂質含有脂質粒子bを含有する、免疫賦活剤。【選択図】なし</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; jpn |
| recordid | cdi_epo_espacenet_JP2020090445A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | IMMUNOSTIMULATOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T11%3A07%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MORI%20YASUKO&rft.date=2020-06-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2020090445A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |